Our observation that CD44 repression results in decreased invasiveness (Fig. 5) and migration (Fig. S4) in breast cancer cells is consistent with the notion that CD44 expression is one of the key determinants of the migration and invasiveness of cancer cells. The gene discussed is CD44; the disease is breast cancer.